Edesa Biotech
EDSA
17 hedge funds and large institutions have $1.37M invested in Edesa Biotech in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, reducing their positions, and 0 closing their positions.
77% more capital invested
Capital invested by funds: $774K → $1.37M (+$595K)
13% more funds holding
Funds holding: 15 → 17 (+2)
0.13% more ownership
Funds ownership: 0.16% → 0.28% (+0.13%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$297K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$259K |
| 3 |
1WA
180 Wealth Advisors
Federal Way,
Washington
|
+$86.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$21.7K |
| 5 |
VF
Virtu Financial
New York
|
+$16.2K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $576K | +$297K | +7,338 | +89% |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $390K | +$259K | +6,400 | +153% |
|
3
Stifel Financial
St. Louis,
Missouri
| $124K | – | – | – |
|
|
VF
4
Virtu Financial
New York
| $100K | +$16.2K | +400 | +17% |
|
5
Northern Trust
Chicago,
Illinois
| $81K | – | – | – |
|
|
1WA
6
180 Wealth Advisors
Federal Way,
Washington
| $70K | +$86.8K | +2,143 | New |
|
|
7
UBS Group
Zurich,
Switzerland
| $20K | +$21.7K | +535 | +10,700% |
|
8
Fifth Third Bancorp
Cincinnati,
Ohio
| $4K | – | – | – |
|
9
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | – | – | – |
|
10
Osaic Holdings
Scottsdale,
Arizona
| $1K | – | – | – |
|
|
FDCDDQ
11
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $713 | – | – | – |
|
|
APA
12
American Portfolios Advisors
Holbrook,
New York
| $11 | – | – | – |
|
13
Bank of America
Charlotte,
North Carolina
| – | +$284 | +7 | New |
|
EDSA Hedge Fund Activity: Q2 2021 in Review
17 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q2 2021, worth a combined $1.37M — up 77% from $774K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new EDSA positions and 0 closed out — a net gain of 2 holders — while 4 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, adding an estimated $297K.
- 17 institutional investors held Edesa Biotech (EDSA) as of Q2 2021, up from 15 in Q1 2021.
- Funds reported $1.37M of Edesa Biotech stock for Q2 2021, up 77% quarter-over-quarter.
- 2 funds opened new Edesa Biotech positions in Q2 2021 and 0 closed out, a net change of +2 holders.
- The largest Edesa Biotech buyer in Q2 2021 was Vanguard Group, an estimated $297K added.
Based on aggregated 13F filings for Q2 2021.